These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Readers' responses to the article entitled "anticoagulation therapy for venous thromboembolism". Sarsfield RG MedGenMed; 2005; 7(1):49; author reply 48. PubMed ID: 16382537 [No Abstract] [Full Text] [Related]
3. Readers' responses to the article entitled "anticoagulation therapy for venous thromboembolism". Markowicz A MedGenMed; 2005; 7(1):49; author reply 48. PubMed ID: 16382536 [No Abstract] [Full Text] [Related]
4. Readers' responses to the article entitled "anticoagulation therapy for venous thromboembolism". Hoyt R MedGenMed; 2005 Jan; 7(1):49; author reply 48. PubMed ID: 16369354 [No Abstract] [Full Text] [Related]
5. Long term anticoagulation of idiopathic venous thromboembolism: do we have the answers? Goldhaber S Clin Adv Hematol Oncol; 2003 May; 1(5):276-7. PubMed ID: 16224420 [No Abstract] [Full Text] [Related]
6. [Current concepts of venous thromboembolism and anticoagulation during pregnancy]. Collado Peña S; Villanueva LA Ginecol Obstet Mex; 2004 Apr; 72():150-61. PubMed ID: 15318755 [TBL] [Abstract][Full Text] [Related]
7. [Ximelagatran for treatment of venous thromboembolism]. Harenberg J; Fenyvesi T; Jörg I Hamostaseologie; 2002 Aug; 22(3):25-9. PubMed ID: 12215758 [TBL] [Abstract][Full Text] [Related]
8. Guidelines for anticoagulation therapy for venous thromboembolism. Cundiff DK J Gen Intern Med; 2002 Jan; 17(1):85. PubMed ID: 11903782 [No Abstract] [Full Text] [Related]
9. The optimal long-term treatment of venous thromboembolism. Prandoni P Clin Adv Hematol Oncol; 2004 Nov; 2(11):729-32. PubMed ID: 16170889 [No Abstract] [Full Text] [Related]
10. Low-molecular-weight heparin in treatment of venous thromboembolism. An emerging theme. Hull RD; Pineo GF Int Angiol; 1998 Sep; 17(3):131-4. PubMed ID: 9821024 [No Abstract] [Full Text] [Related]
11. Emerging anticoagulants for the treatment of venous thromboembolism. Weitz JI Thromb Haemost; 2006 Sep; 96(3):274-84. PubMed ID: 16953267 [TBL] [Abstract][Full Text] [Related]
12. New pharmacologic strategies for arterial and venous thromboembolism. Agnelli G Haematologica; 2001 Nov; 86(11 Suppl 2):58. PubMed ID: 11926780 [No Abstract] [Full Text] [Related]
13. Duration of anticoagulation after first episode of unprovoked venous thromboembolism. Abdel-Razeq HN; Radwi GR Saudi Med J; 2004 Nov; 25(11):1776; author reply 1776-7. PubMed ID: 15573235 [No Abstract] [Full Text] [Related]
14. Standard-intensity vs low-dose anticoagulation for long-term management of patients with venous thromboembolism. Lazo-Langner A; Kovacs MJ Clin Adv Hematol Oncol; 2005 Nov; 3(11):877-9. PubMed ID: 16491633 [No Abstract] [Full Text] [Related]
16. Clearing the way: treating venous thromboembolism and deep vein thrombosis. Lambing A Adv Nurse Pract; 2005 Jun; 13(6):24-30; quiz 31. PubMed ID: 15984353 [No Abstract] [Full Text] [Related]
17. Management of venous thromboembolism: present and future. Weitz JI Circulation; 2004 Aug; 110(9 Suppl 1):I2. PubMed ID: 15339874 [No Abstract] [Full Text] [Related]
18. Oral anticoagulation after a first episode of venous thromboembolism: how long? How strong? Watzke HH Thromb Haemost; 1999 Sep; 82 Suppl 1():124-6. PubMed ID: 10695502 [TBL] [Abstract][Full Text] [Related]